Sustained release hydrogel with bupivacaine (Insitu Biologics)

N/A

Report date: 2025/05/20 17:40:10

Base Information

Drug NameSustained release hydrogel with bupivacaine (Insitu Biologics)
Drug Alias NameAnestaGel
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel alpha subunit blockers
TargetsSodium channel alpha subunit
Therapy Area/IndicationsPain, Postoperative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInSitu Biologics Inc
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of MinnesotaInSitu Biologics Inc
Inactive CompaniesN/A
Active IndicationsPain, Postoperative
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A